Walleye Capital LLC Elevation Oncology, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.35 - $5.17 $401,255 - $882,761	-170,747 Reduced 21.71%	615,837 $1.66 Million
Q1 2024 May 15, 2024	BUY	$0.59 - $5.13 $464,084 - $4.04 Million	786,584 New	786,584 $4.04 Million
Q3 2023 Nov 14, 2023	BUY	$0.65 - $1.56 $29,417 - $70,600	45,257 Added 43.67%	148,887 $98,000
Q2 2023 Aug 14, 2023	SELL	$1.4 - $5.06 $463,145 - $1.67 Million	-330,818 Reduced 76.15%	103,630 $157,000
Q1 2023 May 15, 2023	BUY	$0.75 - $2.55 $325,836 - $1.11 Million	434,448 New	434,448 $825,000

45.4M

700

27.6K

Ticker ELEV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,300,900
Market Cap $13.5M
Description
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.